SARS-CoV-2 Seroprevalence Low in U.S. From July to Sept. 2020
Jurisdiction-level seroprevalence varied from less than 1 percent to 23 percent across four collection periods
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.